Unlike traditional diabetes medications that target only GLP-1, Tirzepatide activates both GIP and GLP-1 receptors to optimize blood sugar control through multiple pathways: Enhances Insulin Secretion Tirzepatide stimulates insulin release from the pancreas in response to elevated blood sugar levels
Not too much, but not too little, and you'll still want to get your sunshine in, especially when you can
The gut anaerobe faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases
This mechanism is critical because neurons have a limited ability to synthesize endogenous GS (Dringen and Arend, 2025)
Almuerzo: Incorpore legumbres a ensaladas o sopas
Bottom Line GLP-1 drugs are not currently FDA-approved for people who dont have obesity or diabetes, but clinicians increasingly recognize the benefits of losing 10 to 30 pounds with GLP-1 therapy